Defence Therapeutics Inc.

DTC.CNCNQHealthcare● Active

$0.50

$-0.01(-1.96%)

Market Cap$28684985

P/E Ratio—

52W High$0.93

52W Low$0.435

Avg Volume43K

Open$0.52

Beta1.40

Earnings Financials Revenue

Defence Therapeutics Inc. (DTC.CN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DTC.CN · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2025Report Date: Mar 31, 2025

EPS Actual

-$0.02

Revenue

—

Fiscal Period

Q1 FY2025

FY ends December

Report Date

Mar 31, 2025

After Market Close

DTC.CN reports quarterly as a CNQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2025	Mar 31, 2025	—	-$0.02	—	—	—	—
— Q4 FY2024	Dec 31, 2024	—	-$0.02	—	—	—	—
— Q3 FY2024	Sep 30, 2024	—	-$0.01	—	—	—	—
— Q2 FY2024	Jun 30, 2024	—	-$0.03	—	—	—	—
— Q1 FY2024	Mar 31, 2024	—	-$0.03	—	—	—	—
— Q4 FY2023	Dec 31, 2023	—	-$0.19	—	—	—	—
— Q3 FY2023	Sep 30, 2023	—	-$0.05	—	—	—	—
— Q2 FY2023	Jun 29, 2023	—	-$0.04	—	—	—	—

Q1 FY2025

Mar 31, 2025

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 31, 2024

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 30, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 30, 2024

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 31, 2024

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Dec 31, 2023

EPS Actual

-$0.19

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2023

Sep 30, 2023

EPS Actual

-$0.05

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2023

Jun 29, 2023

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for DTC.CN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2025	Mar 31, 2025	—	$1.04	$1.05	+0.96%
— Q4 FY2024	Dec 31, 2024	—	$0.62	$0.66	+6.45%
— Q3 FY2024	Sep 30, 2024	—	$0.58	$0.55	-5.17%
— Q2 FY2024	Jun 30, 2024	—	$0.73	$0.80	+9.59%
— Q1 FY2024	Mar 31, 2024	—	$1.71	$1.68	-1.75%
— Q4 FY2023	Dec 31, 2023	—	$2.33	$2.34	+0.43%
— Q3 FY2023	Sep 30, 2023	—	$2.50	$2.52	+0.80%
— Q2 FY2023	Jun 29, 2023	—	$2.82	$2.85	+1.06%

Q1 FY2025+0.96%

Report Date

Mar 31, 2025

EPS Beat/Miss

—

Price Before

$1.04

Price After

$1.05

Q4 FY2024+6.45%

Report Date

Dec 31, 2024

EPS Beat/Miss

—

Price Before

$0.62

Price After

$0.66

Q3 FY2024-5.17%

Report Date

Sep 30, 2024

EPS Beat/Miss

—

Price Before

$0.58

Price After

$0.55

Q2 FY2024+9.59%

Report Date

Jun 30, 2024

EPS Beat/Miss

—

Price Before

$0.73

Price After

$0.80

Q1 FY2024-1.75%

Report Date

Mar 31, 2024

EPS Beat/Miss

—

Price Before

$1.71

Price After

$1.68

Q4 FY2023+0.43%

Report Date

Dec 31, 2023

EPS Beat/Miss

—

Price Before

$2.33

Price After

$2.34

Q3 FY2023+0.80%

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$2.50

Price After

$2.52

Q2 FY2023+1.06%

Report Date

Jun 29, 2023

EPS Beat/Miss

—

Price Before

$2.82

Price After

$2.85

Beat Rate0 / 8 quarters

Largest Move+9.59% (Q2 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Defence Therapeutics Inc. (DTC.CN) most recently reported earnings on March 31, 2025 for Q1 FY2025, posting EPS of $-0.02 (in line with the analyst consensus of —). The next DTC.CN earnings date is expected around September 1, 2026.

Each quarter, investors track DTC.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DTC.CN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

DTC.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

DTC.CN earnings · 4 questions

Defence Therapeutics Inc.'s next earnings report is expected around September 1, 2026. DTC.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DTC.CN historically reports after market close (AMC).

DTC.CN earnings datewhen is DTC.CN earningsDTC.CN next earnings datewhen does DTC.CN report earningsDTC.CN earnings calendar

▸ Source: FMP · Defence Therapeutics Inc. SEC filings · US GAAP · Defence Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026